Generated by GPT-5-mini| Krebs cycle | |
|---|---|
| Name | Krebs cycle |
| Substrates | Acetyl-CoA |
| Products | CO2, NADH, FADH2, GTP/ATP |
| Location | Mitochondrial matrix |
| Enzymes | Citrate synthase; Aconitase; Isocitrate dehydrogenase; α-Ketoglutarate dehydrogenase; Succinyl-CoA synthetase; Succinate dehydrogenase; Fumarase; Malate dehydrogenase |
Krebs cycle The Krebs cycle is a central metabolismal pathway in aerobic cellular respiration that oxidizes acetyl groups to carbon dioxide while reducing electron carriers for use in the electron transport chain. It operates in the mitochondrial matrix of Eukaryota and in the cytosol or specialized organelles of various Bacteria and Archaea, linking catabolic and anabolic processes. The cycle’s enzymes and intermediates connect to pathways such as glycolysis, fatty acid beta-oxidation, and amino acid degradation, integrating energy production with biosynthesis and redox balance.
The pathway begins with condensation of acetyl-CoA and an oxaloacetate acceptor catalyzed by citrate synthase and proceeds through a series of oxidation, decarboxylation, and substrate-level phosphorylation reactions to regenerate oxaloacetate. Key electron carriers produced include NADH and FADH2, which feed reducing equivalents into the mitochondrial electron transport chain and ultimately drive oxidative phosphorylation via ATP synthase. Intermediates such as α-Ketoglutarate, Succinyl-CoA, and Oxaloacetate serve as precursors in anabolic routes including gluconeogenesis, heme synthesis in the liver, and amino acid transamination in the kidney.
The cycle’s canonical sequence comprises eight enzymatic steps: condensation by citrate synthase forming citrate; isomerization by aconitase to isocitrate; oxidative decarboxylation by isocitrate dehydrogenase yielding α-ketoglutarate and CO2; further oxidative decarboxylation by the α-ketoglutarate dehydrogenase complex producing succinyl-CoA and CO2; conversion by succinyl-CoA synthetase to succinate with substrate-level phosphorylation to GTP/ATP; oxidation by succinate dehydrogenase (Complex II) to fumarate producing FADH2; hydration by fumarase to malate; and oxidation by malate dehydrogenase regenerating oxaloacetate and yielding NADH. Transport systems such as the pyruvate dehydrogenase complex supply acetyl-CoA from pyruvate, while shuttles like the malate-aspartate shuttle and glycerol phosphate shuttle manage cytosolic reducing equivalents.
Control is exerted at key irreversible steps by allosteric effectors, covalent modification, and substrate availability. Pyruvate dehydrogenase complex activity is regulated by phosphorylation via pyruvate dehydrogenase kinase and dephosphorylation by pyruvate dehydrogenase phosphatase, linking to hormonal signals mediated by insulin and glucagon. Within the cycle, citrate synthase, isocitrate dehydrogenase, and the α-ketoglutarate dehydrogenase complex are principal control points responsive to ratios of ATP, ADP, AMP, NADH, and Ca2+ concentration; feedback inhibition by NADH and ATP integrates signals from muscle contraction and exercise physiology. Metabolic cross-talk with the pentose phosphate pathway and fatty acid synthesis adjusts flux according to cellular demand.
Different organisms exhibit modified tricarboxylic acid pathways: some Bacteria and Archaea possess the reverse or reductive tricarboxylic acid cycle employed in autotrophic CO2 fixation, while others use branched or partial variants such as the glyoxylate cycle in Mycobacterium tuberculosis and plants enabling conversion of acetyl-CoA to four-carbon dicarboxylic acids during seedling growth. Anaerobic microorganisms may utilize truncated cycles or alternative enzymes like fumarate reductase under anaerobic respiration in environments studied by expeditions to Hydrothermal vents and isolated in soil microbiology surveys. Evolutionary analyses compare enzyme homologs across taxa including Escherichia coli, Saccharomyces cerevisiae, and Arabidopsis thaliana to infer ancient metabolic routes relevant to the last universal common ancestor.
Beyond ATP generation, the cycle supplies carbon skeletons for biosynthesis: α-ketoglutarate and oxaloacetate are precursors for amino acids involved in transamination reactions in the liver and brain; succinyl-CoA contributes to heme biosynthesis in erythropoiesis; and citrate exported to the cytosol supplies acetyl units for fatty acid synthesis in the adipose tissue. Dysregulation is implicated in inherited metabolic disorders such as mutations affecting the α-ketoglutarate dehydrogenase complex and in acquired conditions including ischemia-reperfusion injury in myocardial infarction and metabolic reprogramming in cancer cells characterized by alterations in TCA flux and oncometabolite accumulation. Pharmacological targeting of cycle enzymes is explored in contexts ranging from antibiotic development to metabolic disease therapeutics.
The pathway was elucidated through biochemical studies culminating in work by scientists including Sir Hans Krebs and collaborators, who integrated observations from metabolic tracer experiments and enzymology. Early research involving techniques pioneered in laboratories at institutions such as the University of Oxford and connections to contemporaneous studies by researchers in Berlin and Cambridge established the cycle’s sequence and energetic role, leading to recognition including the Nobel Prize in Physiology or Medicine awarded to Hans Krebs. Subsequent advances in chromatography, isotope labeling, and structural biology by groups at institutions like the Max Planck Society and Harvard University refined understanding of enzyme mechanisms and regulation.